Adrian F. Ochsenbein

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.2K citations · Full text

Control of Early Viral and Bacterial Distribution and Disease by Natural Antibodies

Adrian F. Ochsenbein, Thomas Fehr, Claudia Lutz et al. · Science · 1999 · 907 citations

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

Adrian F. Ochsenbein, Sophie Sierro, Bernhard Odermatt et al. · Nature · 2001 · 490 citations

Tumor Biology, Cancer Immunosurveillance, Medicine +10

Immune surveillance against a solid tumor fails because of immunological ignorance

Adrian F. Ochsenbein, Paul Klenerman, Urs Karrer et al. · Proceedings of the National Academy of Sciences · 1999 · 451 citations · Full text

Vaccination, Immunological Ignorance, Immune Evasion +15

Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma

Roger Stupp, Monika E. Hegi, Bart Neyns et al. · Journal of Clinical Oncology · 2010 · 439 citations · Full text